» Articles » PMID: 33823629

Improving Quality Management of Newborn Screening in Southwest China

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2021 Apr 7
PMID 33823629
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Newborn screening (NBS) programs benefit tens of millions of infants worldwide each year. However, the extremely large screening populations and number of laboratories involved pose great challenges to maintaining high screening quality. To achieve continuous quality improvement, we established a comprehensive quality management system (CQMS) in southwest China.

Methods: External quality assessment (EQA) and internal quality control were carried out for basic quality management. We used 16 quality indicators (QIs) to monitor the entire screening process, with external supervision from the China National Accreditation Service for Conformity Assessment. All retrospective data for quality assessment were collected consecutively from laboratory management and patient follow-up systems.

Results: From 2015 to 2019, satisfactory EQA performance was achieved, with an average score greater than 97 for each screening item. QI monitoring showed that NBS quality improved continuously. The rate of health education provision increased from 90.9% to 100% and the recall rate after a positive primary screening increased from 85.4% to 99.2%. The unsatisfactory specimen rate and rate of newborns lost to follow-up decreased to 0.38% and 0.08%, respectively.

Conclusions: Implementing a CQMS and monitoring the whole screening process using QIs may yield continuous quality improvement of NBS.

Citing Articles

Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).

Therrell B, Padilla C, Borrajo G, Khneisser I, Schielen P, Knight-Madden J Int J Neonatal Screen. 2024; 10(2).

PMID: 38920845 PMC: 11203842. DOI: 10.3390/ijns10020038.


Up-to-date quality survey and evaluation of neonatal screening programs in China.

Zhang J, Jin L, Feng P, Fei Y, Li W, Jiang T BMC Pediatr. 2024; 24(1):65.

PMID: 38245686 PMC: 10799474. DOI: 10.1186/s12887-024-04528-1.


Harmonization of distributed multi-center analysis based on dried blood spot reference materials supporting the screening of neonatal inherited metabolic disorders.

Qu S, Tao H, Qin L, Zhang W, Han S, Zhang S J Clin Lab Anal. 2023; 37(19-20):e24970.

PMID: 37837220 PMC: 10681404. DOI: 10.1002/jcla.24970.


Impact of accreditation on health care services performance in Kiryandongo district, Uganda: a longitudinal study.

Matovu M, Musiime E, Olak P, Mulindwa M, Namisango E, Songwe K BMC Health Serv Res. 2022; 22(1):174.

PMID: 35144593 PMC: 8830999. DOI: 10.1186/s12913-022-07603-4.

References
1.
Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D . SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf. 2015; 25(12):986-992. PMC: 5256233. DOI: 10.1136/bmjqs-2015-004411. View

2.
De Jesus V, Mei J, Bell C, Hannon W . Improving and assuring newborn screening laboratory quality worldwide: 30-year experience at the Centers for Disease Control and Prevention. Semin Perinatol. 2010; 34(2):125-33. DOI: 10.1053/j.semperi.2009.12.003. View

3.
Du Y, Wang W, Liu J, Zhang Z, Zhao Z, He F . National Program for External Quality Assessment of Chinese Newborn Screening Laboratories. Int J Neonatal Screen. 2020; 6(2):38. PMC: 7422995. DOI: 10.3390/ijns6020038. View

4.
Kumar B, Mohan T . Sigma metrics as a tool for evaluating the performance of internal quality control in a clinical chemistry laboratory. J Lab Physicians. 2018; 10(2):194-199. PMC: 5896188. DOI: 10.4103/JLP.JLP_102_17. View

5.
Zhong K, Wang W, He F, Wang Z . The status of neonatal screening in China, 2013. J Med Screen. 2015; 23(2):59-61. DOI: 10.1177/0969141315597715. View